다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Virpax Pharmaceuticals Inc (VRPX)
Virpax Pharmaceuticals Inc (VRPX) 뉴스

VRPX

Virpax Pharmaceuticals (VRPX)

Virpax Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VRPX

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/29	20:30	Business Wire	Virpax® Pharmaceuticals to Present at 2024 BIO International Convention	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/18	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/17	05:00	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/15	21:00	Business Wire	Virpax Announces Pricing of $2.25 Million Public Offering	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/15	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/14	06:30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/14	05:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/14	05:10	Business Wire	Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/05/14	05:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/04/30	20:30	Business Wire	Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/03/26	20:30	Business Wire	Virpax Pharmaceuticals Reports 2023 Year-End Results	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/27	21:31	Business Wire	Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/27	21:30	Business Wire	Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/07	21:30	Business Wire	Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2024/02/01	06:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/12/29	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/12/29	21:30	Business Wire	Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/12/13	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/12/07	23:08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/12/07	22:58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/12/07	22:50	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/11/22	06:57	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:VRPX	Virpax Pharmaceuticals Inc
2023/11/17	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRPX	Virpax Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VRPX

1 2 3 4 5 6 7 다음 >>

Verizon Communications

BNP Paribas (QX)

Bank of America

US Dollar vs Yen

Deutsche Telekom (QX)

US Dollar vs Euro

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관